Sentence examples for more predictable disease from inspiring English sources

Although patients with terminal cancer can have a more predictable disease trajectory compared with non-malignant illnesses, difficulties in accurate prognostication mean a significant proportion of cancer patients will continue to die in the acute hospital (Dunlop et al, 1989; Auret et al, 2003).

To improve the utility of C3HeB/FeJ mice for more routine drug efficacy testing, it would be useful to develop either a means of creating more predictable and uniform disease progression and/or to develop more effective ways of tracking the treatment response in individual mice to minimize the negative impact of heterogeneity on the power to determine differences between treatments.

In contrast, Mendelian diseases demonstrate more predictable heritability patterns and often represent highly penetrant phenotypes.

They have been shown to be effective in the prevention and treatment of various thromboembolic diseases with more predictable anticoagulant response and no need for close laboratory monitoring.

Doctors do best in providing accurate prognoses for patients with advanced cancer, because the disease follows a more predictable course and the medical literature provides a range of survival times for most cancers.

Further, this strategy could significantly improve and accelerate the design and establishment of new clinical trials to identify novel and improved therapies for this devastating disease in a more predictable way.

One explanation could be a slower and often more predictable progression of HCV-induced liver disease compared to other liver conditions.

Therapeutic treatment by injection will achieve more predictable plasma drug levels, enhancing opportunities for disease control (Baggot 2007; Lees et al. 2006).

Thus, in non-Caucasian populations with chronic liver disease, HFE-HH diagnosis is more predictable in those with iron levels higher than those proposed in current guidelines for the general population.

In order to most accurately represent disease spread mimicking human EC as well as more predictable therapeutic efficacy, we utilize an orthotopic xenograft mouse model to demonstrate the in vivo activity of HCI2509 against poorly differentiated Type II EC.

This optimized approach allows targeted transgene integration into safe harbor sites for more predictable and robust expression and enables the straightforward generation of disease-corrected, patient-derived iPSC lines for research purposes and, ultimately, for future clinical applications.